Latest C-peptide Stories
Largest Study to Date of Residual Insulin Production Proves Such Patients Are Not 'Exceptional' BOSTON, Dec.
Transparency Market Research includes new market research report "Peptide Therapeutics Market:Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 – 2018" to its
Researchers recently discovered that a tuberculosis vaccine could decrease autoimmunity and boost insulin production in patients who have long-term Type 1 diabetes.
A phase I clinical trial has confirmed that use of a generic vaccine to raise levels of an immune system modulator can cause the death of autoimmune cells targeting the insulin-secreting cells of the pancreas and temporarily restore insulin secretion in human patients with type 1 diabetes.